KRAS and malignant colon neoplasm: Application of the p38γ inhibitor pirfenidone (PFD) blocked p38γ-induced HSP90/S595 phosphorylation, promoted mutant KRAS degradation, and inhibited colon cancer xenograft growth in nude mice [58].